KeyBanc on Life Sciences Tools & Services: 'We Highlight Our Favored 2026 "Tools" Stocks' Dec 8, 2025 07:11AM
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure' Sep 30, 2025 07:55AM
KeyBanc: 'Cell & Gene Therapy Getting More Support; BLFS, CYRX, TKNO With the Most Exposure' Sep 30, 2025 07:55AM
KeyBanc Upgrades CryoPort (CYRX) to Overweight Aug 6, 2025 02:57AM
KeyBanc Reiterates Sector Weight on CryoPort (CYRX) Amid DHL Partnership & Asset Sale Apr 1, 2025 06:43AM


Mar 11, 2022 03:41PM Cryoport (CYRX) Authorizes $100 Million Repurchase Program
Sep 30, 2020 06:58AM Companies with NDRs 09/30
Sep 29, 2020 07:18AM Companies with NDRs 09/29
Apr 2, 2020 07:24AM Companies with NDRs 4/02
Apr 1, 2020 06:55AM Companies with NDRs 4/01